All News about Blueprint Medicines Corp
![](/next-assets/images/schema-image-default.png)
16 Analysts Have This to Say About Blueprint Medicines
March 30, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/29/bpmc.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](/next-assets/images/schema-image-default.png)
Where Blueprint Medicines Stands With Analysts
February 27, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/27/bpmc_logo_light__d4d17d70d27028c99b52b000612c5b7d.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/23/bpmc_blueprint_medicines_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_111.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Blueprint Medicines
February 15, 2023
Via Benzinga
Analyst Ratings for Blueprint Medicines
January 23, 2023
Via Benzinga
Where Blueprint Medicines Stands With Analysts
December 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/10/bpmc_logo_light__d4d17d70d27028c99b52b000612c5b7d.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3442.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/02/bpmc_logo_light__d4d17d70d27028c99b52b000612c5b7d.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29034.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6766.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_1772.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_2994.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/18/aapharma_15.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/02/image-uber.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_3422.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Via Benzinga
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_1886.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220819005265/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/22/image47.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220818005710/en/827144/5/Schall-Firm-Logo-640x360.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/18/image_6.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/17/bz-pharma_3.jpg?width=1200&height=800&fit=crop)
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 17, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.